ANALYSIS OF OUTPATIENT UTILIZATION AND COSTS OF ANTITHROMBOTIC DRUGS IN POLAND - IMPLICATIONS FOR PHARMACEUTICAL PRICING AND REIMBURSEMENT POLICY

被引：0
|
作者：
Bochenek, T. [1 ]
Nizankowski, R. [1 ]
机构：
[1] Jagiellonian Univ, Coll Med, Krakow, Poland
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1051
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A381 / A382
页数：2
相关论文
共 50 条
  • [1] Are pharmacological properties of anticoagulants reflected in pharmaceutical pricing and reimbursement policy? Out-patient treatment of venous thromboembolism and utilization of anticoagulants in Poland
    Bochenek, T.
    Czarnogorski, M.
    Nizankowski, R.
    Pilc, A.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (11) : 1649 - 1656
  • [2] Stakeholder preferences about policy objectives and measures of pharmaceutical pricing and reimbursement
    Vogler, Sabine
    Zimmermann, Nina
    Habimana, Katharina
    [J]. HEALTH POLICY AND TECHNOLOGY, 2016, 5 (03) : 213 - 225
  • [3] Pharmaceutical Pricing and Reimbursement in Japan: For Faster, More Complete Access to New Drugs
    Akane Takayama
    Mamoru Narukawa
    [J]. Therapeutic Innovation & Regulatory Science, 2016, 50 : 361 - 367
  • [4] Pharmaceutical Pricing and Reimbursement in Japan: For Faster, More Complete Access to New Drugs
    Takayama, Akane
    Narukawa, Mamoru
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (03) : 361 - 367
  • [5] On the welfare analysis of external reference pricing and reimbursement policy
    Dong, Van-Chung
    Lin, Yan-Shu
    Shih, Pei-Cyuan
    [J]. ESTUDIOS DE ECONOMIA, 2023, 50 (01): : 133 - 158
  • [6] The Pricing of Breakthrough Drugs: Theory and Policy Implications
    Levy, Moshe
    Nir, Adi Rizansky
    [J]. PLOS ONE, 2014, 9 (11):
  • [7] Pharmaceutical pricing policy in Saudi Arabia: findings and implications
    Alrasheedy, Allan A.
    [J]. GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2020, 9 (01): : 14 - 21
  • [8] The Pharmaceutical Pricing and Reimbursement Information (PPRI) initiative-Experiences from engaging with pharmaceutical policy makers
    Vogler, Sabine
    Leopold, Christine
    Zimmermann, Nina
    Habl, Claudia
    de Joncheere, Kees
    [J]. HEALTH POLICY AND TECHNOLOGY, 2014, 3 (02) : 139 - 148
  • [9] ANALYSIS OF COSTS AND REIMBURSEMENT OF HOSPITAL TREATMENT OF VENOUS THROMBOEMBOLISM IN POLAND
    Bochenek, T.
    Nizankowski, R.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A531 - A531
  • [10] The Pharmaceutical Pricing and Reimbursement Information (PPRI) network – a decade of exchange of information and policy research?
    Sabine Vogler
    Nina Zimmermann
    Kees De Joncheere
    [J]. Journal of Pharmaceutical Policy and Practice, 8 (Suppl 1)
12345